Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Explore which Dividend Aristocrats Etf Has The Lowest Fees and why cost matters for long-term growth. Use this guide to choose efficiently.
27,609 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Nvidia is fueling a bold thesis for H2 2026 as AI infrastructure demand climbs. With data-center momentum and locked-...
As AI builds out more data centers, the U.S. power grid faces mounting strain. HPE’s warning of a looming 19 gigawatt...
Honeywell Aerospace becomes an independent company after the June 29, 2026 spin-off, offering a focused aerospace exp...
An appeals court clears the Trump administration to reinstall interpretive panels at George Washington's Philadelphia...
Ethereum fails to sustain a rebound toward the $2,000 level as a fresh pullback tests support and resistance dynamics...
The Strait of Hormuz remains blocked by a widening U.S.-Iran conflict, fueling volatility in oil prices and household...
NVIDIA is forecast to surpass Apple in market capitalization by late July, even as Apple posts faster near-term growt...
Bank of America named two new leaders to oversee digital assets and AI transformation, signaling a strategic push to ...
A hypothetical summer of mega-deals could redefine streaming. This article explains what Netflix should consider if F...
Biotech investing often feels unpredictable. This year, agios stock down year highlights how big investor moves and l...
A fresh AI-driven marketing platform launches a Reg A+ offering at $0.85 per share, claiming strong ROI through AI-po...